SIRT1 and type 2 diabetes mellitus: However, treatment with PEG-Loxe and Lira improved markedly, suggesting that PEG-Loxe can inhibit hepatic lipid synthesis and oxidative stress, and promote fatty acid oxidation by regulating lipid metabolism via the Sirt1-AMPK pathway, thereby improving liver damage in T2DM.